Formidable Asset Management’s United Therapeutics UTHR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$607K	Sell	1,024 -36	-3%	-$17.9K	0.09%	198
2025 Q4	$516K	Sell	1,060 -1,000	-49%	-$466K	0.08%	246
2025 Q3	$864K	Hold	2,060	–	–	0.14%	150
2025 Q2	$592K	Buy	2,060 +97	+5%	+$29K	0.1%	201
2025 Q1	$605K	Hold	1,963	–	–	0.1%	199
2024 Q4	$693K	Buy	1,963 +504	+35%	+$185K	0.11%	171
2024 Q3	$523K	Sell	1,459 -108	-7%	-$36.5K	0.08%	218
2024 Q2	$499K	Sell	1,567 -1,811	-54%	-$479K	0.08%	234
2024 Q1	$777K	Sell	3,378 -172	-5%	-$38.8K	0.13%	169
2023 Q4	$781K	Sell	3,550 -86	-2%	-$19.8K	0.16%	119
2023 Q3	$821K	Buy	3,636 +53	+1%	+$12.2K	0.18%	105
2023 Q2	$791K	Buy	3,583 +354	+11%	+$78.4K	0.17%	116
2023 Q1	$723K	Buy	3,229 +1,399	+76%	+$345K	0.15%	130
2022 Q4	$509K	Sell	1,830 -500	-21%	-$126K	0.12%	162
2022 Q3	$491K	Buy	2,330 +51	+2%	+$11.4K	0.11%	159
2022 Q2	$536K	Buy	2,279 +139	+6%	+$28.3K	0.12%	157
2022 Q1	$384K	Sell	2,140 -43	-2%	-$8.19K	0.07%	223
2021 Q4	$472K	Buy	+2,183	New	+$429K	0.09%	194